Form 8-K - Current report:
SEC Accession No. 0001193125-25-122461
Filing Date
2025-05-19
Accepted
2025-05-19 16:16:35
Documents
12
Period of Report
2025-05-19
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d50434d8k.htm   iXBRL 8-K 26203
  Complete submission text file 0001193125-25-122461.txt   140487

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sdgr-20250519.xsd EX-101.SCH 2862
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE sdgr-20250519_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sdgr-20250519_pre.xml EX-101.PRE 11269
15 EXTRACTED XBRL INSTANCE DOCUMENT d50434d8k_htm.xml XML 3662
Mailing Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036
Business Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Filer) CIK: 0001490978 (see all company filings)

EIN.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39206 | Film No.: 25964135
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)